Under the terms of the agreement, ViaNautis will receive an initial upfront payment from Lilly, with the short-term potential for additional payments including research-based milestones. Further ...

The University of Edinburgh Scotland has invited interested scholars to apply for an opportunity to pursue their PhD in the school for free under a scholarship.

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...

Presentations include results from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive therapy to antidepressants ...

Intracellular dark endothelial spots (IDESs) on specular microscopy developed in 78/122 patients (63.9%) after Descemet stripping automated endothelial keratoplasty (DSAEK). Endothelial cell density ...

Researchers found that Toxoplasma gondii increased the host cell’s metabolic activity, offering insights into potential ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $81 ...

Can a common parasite help treat Alzheimer’s? Scientists say Toxoplasma gondii may open pathways to brain therapies for ...

Inter-organelle communication via the formation of membrane contact sites (MCS) is essential for cell homeostasis. Bacterial pathogens residing in membrane bound vacuoles have exploited this ...

Presented additional data from the Phase 1 clinical trial ENTR-601-44-101 and new preclinical data supporting ENTR-601-45 for DMD at 2024 World Muscle Society Annual Congress – – On track to submit gl ...

(RTTNews) - Intra-Cellular Therapies, Inc. (ITCI), Tuesday announced positive data from phase 3 trial of Lumateperone, marketed as Caplyta, for the prevention of relapse in adult patients with ...

Researchers from the UCLA Samueli School of Engineering and the University of Rome Tor Vergata in Italy have developed ...